Effect of low dose acetylsalicylic acid and anticoagulant on clinical outcomes in COVID‐19, analytical cross‐sectional study

Effect of low dose acetylsalicylic acid and anticoagulant on clinical outcomes in COVID‐19, analytical cross‐sectional study

Abstract Background and aims The therapeutic strategy for the treatment of known sequelae of COVID‐19 has shifted from reactive to preventative. In this study, we aim to evaluate the effects of acetylsalicylic acid (ASA), and anticoagulants on COVID‐19 related morbidity and mortality. Methods This r...

Full description

Bibliographic Details
Main Authors: Muhammad B. Malik, Samar A. Amer, Eric Merrell, Ronald Russo, Jeffrey B. Riley, Austin Scro, Elizabeth James, Anderson Anuforo, Soumya Adhikari, Rosalie Siciliano, Philip Chebaya, Edward Darling, Michael Kuhn, Gary Nieman, Ahmed Shawkat, Hani Aiash
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Health Science Reports
Subjects:
acetylsalicylic acid
anticoagulation
ASA
COVID‐19
preventative medicine
Online Access:https://doi.org/10.1002/hsr2.699

Internet

https://doi.org/10.1002/hsr2.699

Similar Items